Our mission is to help scientists make better decisions by advancing science, patient care, public health, and technology. The information provided below is for deciding if your following paper is suitable for The Roads Journals and what The Roads Journals has to offer you as an author.

We look for research with a well-constructed idea and proof on the scientific issues, medicine, clinical care, public health, drug discovery, nanotechnology, artificial intelligence solutions, neuroscience, and anatomy, etc. The submitted study should offer something new and vital, with the potential to contribute to policy or practice changes in health and science.

Look forward to hearing from you for:

• Well-designed and constructed scientific problems and their solution are based on work.
• Clinical research compares the effectiveness and safety of drugs, devices, or other healthcare interventions to find optimal applications.
• We offer our authors the assurance that their research will be distributed globally to the scientific community through highly cited and widely read papers in science, medicine, and engineering journals.
• We offer fast decision times through our journal evaluation system, which includes an interactive review. This would allow you to submit your work elsewhere without delay if The Roads Journals declined.

Increasing the impact of your research:

All the evaluation and publication processes are established to maximize the impact of your work. After accepting your paper in The Roads Journals, it will be distributed on social media, and you will be invited to do the same. A press release for your paper will be emailed to our stakeholders so that a broad international audience can see this new publication via various channels: Press releases, commissioned editorials, Opinion pieces, and email alerts.

Open Access:

Articles and research topics, etc., are published under the CC-BY (Creative Commons Attribution) license that allows others to share, adapt, and build upon a work, even commercially, if they provide proper credit to the original creator, with authors retaining copyright. All papers are immediately available in full text via the publisher’s web page and other indexes. Authors may also post their articles on their own and their employer’s website. We charge an article-processing fee, with waivers for those who cannot pay. The requested waiver will be evaluated after application to "info@theroadsin.com".

Open peer review after blindly evaluation stage:

After the first evaluation stage, the review editor will open an interactive stage of the manuscript evaluation. At this stage, the authors and reviewers can see all comments come from both sides. The publisher would provide if the editorial comments and reviewers' reports on the manuscript were requested from a third party based on a written, reasonable explanation.

Transparency:

The publisher aims to improve research quality, integrity, and reproducibility in the medical, engineering, and science fields. This is done in accordance with the editorial policies that promote transparency and accountability at all stages of the paper evaluation process. This would give an editorial power to identify ethically, methodologically, and scientifically robust works. Before evaluating a manuscript and submitting it, reviewers and authors are asked to declare their conflicts of interest and funding sources, respectively. If the submitted work is a clinical trial or an animal-based experiment, it must be prospectively registered and receive ethical approval from the relevant ethical committee before the study begins. The authors are requested to supply the clinical trial protocol; if requested, we may ask the authors to share the anonymized data with third parties.

No word limits:

Although we do not have a word limitation for any submitted work, each word in the manuscript is expected to gain its place. Oversized words in the study would obscure the study's central message. We strictly save time for readers and publishing workers alike.

Involvement of animals and patients in a study:

Animals:

We ask authors to state how animal welfare is addressed; it is a strict issue of the publisher. Ethical issues regarding the use of animals should be clearly explained and receive approval from the relevant community.

Patients:

As patients and caregivers are our stakeholders, we ask the study's authors to indicate the contributions of each party to the design, conduct, analysis, and biological interpretation of the study, and how the study was planned to inform them of the results.

The Roads Journals complies with the guidelines and standards of:

• The International Committee of Medical Journal Editors (ICMJE)
• The Committee on Publication Ethics (COPE)
• The World Association of Medical Editors (WAME),
• The EQUATOR network

For detailed advice on how to submit a research paper, please go to the web page. We prioritize articles that interest doctors and scientists across different specialties, have a widespread impact, and provide essential research information. It must be stated that we do not accept studies that lack specific evidence for evaluation. It is expected that information from studies conducted by scientists and doctors will be up to date, unbiased, and independent. For this reason, the article's authors are requested to disclose a full Conflict of Interest. Articles that do not meet this requirement or are found to be unable to meet this requirement are returned to the author without being evaluated or at any stage of evaluation. For clarity, accuracy, and conciseness of your manuscript, our editorial team and referees will work with you regarding interactive review processes. It is also expected that authors with patient and/or carer stakeholders participate in the writing process and document their involvement as contributors or co-authors. The guidance for authors is available on the web page.

info@theroadsin.com